P20 (Pantoprazole sodium delayed release 20 mg)

Pill imprint P20 has been identified as Pantoprazole sodium delayed release 20 mg.

Pantoprazole is used in the treatment of barrett's esophagus; gerd; dumping syndrome; erosive esophagitis; duodenal ulcer (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 20 mg is not a controlled substance under the Controlled Substance Act (CSA).

Pantoprazole sodium delayed release

Imprint:

P20

Strength:

20 mg

Color:

Yellow

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Proton pump inhibitors

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Wyeth Pharmaceuticals

National Drug Code (NDC):

00008-0606

Inactive Ingredients:

calcium stearate
crospovidone
ferric oxide yellow
mannitol
methacrylic acid - ethyl acrylate copolymer (1:1) type a
polysorbate 80
povidone k25
povidone k90
propylene glycol
sodium carbonate
sodium lauryl sulfate
titanium dioxide
triethyl citrate
hypromellose 2208 (100 mPa.s)

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
00008-0843	Wyeth
54868-4786	Physicians Total Care Inc (repackager)
49999-0755	Lake Erie Medical and Surgical Supply (repackager)
16590-0635	Stat RX USA LLC (repackager)
54868-6038	Physicians Total Care Inc (repackager)
16590-0939	Stat RX USA LLC (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.